Popular
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Precision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
CME/CEPrecision Strikes in AML: Navigating the Evolving Landscape of Targeted Therapies
Harry Erba, MD, PhD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Endobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Clinician's RoundtableEndobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Frank C. Sciurba, MD, FCCP
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Programs
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Key Updates in Bronchoscopic Interventions for COPD Care
Clinician's RoundtableKey Updates in Bronchoscopic Interventions for COPD Care
Frank C. Sciurba, MD, FCCP
Endobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Clinician's RoundtableEndobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Frank C. Sciurba, MD, FCCP
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Recognizing the Mental Burden of Psoriasis
On the Frontlines of PsoriasisRecognizing the Mental Burden of Psoriasis
Mio Nakamura, MD, MS
Steve Jackson, PharmD
Clinical Practice
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Doctors Lounge
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Navigating Vaccine Communication: A Medical Affairs Perspective
MAPSChatsNavigating Vaccine Communication: A Medical Affairs Perspective
Matt Birnholz, MD
Abigail Sporer, PhD, MBA
Designing Smarter Insight Frameworks in Medical Affairs
MAPSChatsDesigning Smarter Insight Frameworks in Medical Affairs
Matt Birnholz, MD
Tony Page
Collaboration in Medical Affairs: Increasing Value and Impact
MAPSChatsCollaboration in Medical Affairs: Increasing Value and Impact
Matt Birnholz, MD
Renu Juneja, PhD
Matt Birnholz, MD
Justin O’Rourke, PhD, MBA
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
CME
Movements With Meaning: Reading the Pattern, Not the Label
CME/CEMovements With Meaning: Reading the Pattern, Not the Label
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
MinuteCE®Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Adam J. Luginbuhl, MD
- NEW EPISODE
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
- NEW EPISODE
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Industry Feature
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Is It Time to Rethink How We Support Depression Management?
Medical Industry FeatureIs It Time to Rethink How We Support Depression Management?
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Gustavo Alva, MD, DFAPA
BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Sharyn N. Lewin, MD, FACS, FACOG
Dana Chase, MD
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Medical Industry FeatureAdvancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Jennifer Caudle, DO, FACOFP
Seth Wander, MD, PhD
Evolving Treatment Approaches in EGFRm NSCLC
Medical Industry FeatureEvolving Treatment Approaches in EGFRm NSCLC
Jennifer Caudle, DO, FACOFP
Hossein Borghaei, MS, DO